Find Post Investigations On:
Facebook Scribd Twitter
Friendfeed RSS Google Reader
» About This Blog | Meet the Investigative Team | Subscribe
Ongoing Investigation

Top Secret America

The Post explores the top secret world the government created in response to the attacks of Sept. 11.

Ongoing Investigation

The Hidden Life of Guns

How guns move through American society, from store counter to crime scene.

Have a Tip?

Talk to Us

If you have solid tips, news or documents on potential ethical violations or abuses of power, we want to know. Send us your suggestions.
• E-mail Us

Categories

Post Investigations
In-depth investigative news
and multimedia from The Washington Post.
• Special Reports
• The Blog

Reporters' Notebook
An insider's guide to investigative news: reporters offer insights on their stories.

The Daily Read
A daily look at investigative news of note across the Web.

Top Picks
A weekly review of the best
in-depth and investigative reports from across the nation.

Hot Documents
Court filings, letters, audits and other documents of interest.

D.C. Region
Post coverage of investigative news in Maryland, Virginia and the District.

Washington Watchdogs
A periodic look into official government investigations.

Help! What Is RSS?
Find out how to follow Post Investigations in your favorite RSS reader.

Hot Comments

Unfortunately I believe that we are limited in what we can focus on. I think that if we proceed with the partisan sideshow of prosecuting Bush admin. officials, healthcare will get lost in the brouhaha.
— Posted by denamom, Obama's Quandary...

Recent Posts
Bob Woodward

The Washington Post's permanent investigative unit was set up in 1982 under Bob Woodward.


Archives
See what you missed, find what you're looking for.
Blog Archive »
Investigations Archive »

Have a Tip?
Send us information on ethics violations or abuses of power.
E-Mail Us »

Other
Investigations
Notable investigative projects from other news outlets.
On the Web »
Top Picks »

Nigerian Press: Pfizer Drug Settlement Fails

POSTED: 02:15 PM ET, 07/ 9/2008 by Derek Kravitz

Infectious Diseases Hospital
The Infectious Diseases Hospital in Kano, Nigeria, was treating meningitis patients in 1996 when Pfizer administered the experimental drug Trovan to children. 2000 photos by Michael Williamson, The Washington Post.

Settlement talks between Pfizer and Nigerian officials broke down last weekend after members of the families of children left injured or dead following a Pfizer drug trial in the West African country more than a decade ago turned down a $10 million compensation offer from the pharmaceutical company.

About 200 Nigerian families who contend their children were harmed rebuked an offer of $10,000 to each victim with "minor deformities" and $100,000 to each victim with "major deformities" or death arising from the Trovan drug test of 1996, the Nigerian Daily Trust reported.

Officials called the offer "demeaning" and "amazing," based on the company's offer to pay $21 million for the settlement of all legal fees incurred by both parties in the case, the newspaper reported.

Pfizer contends that the company actually saved lives during the drug trial, and there is no evidence showing that Trovan actually caused deformity or death.

The clinical drug trial was the subject of a 2000 Post investigation by The Post's Joe Stephens titled "The Body Hunters," which examined drug trials conducted by American corporations in the poorly regulated developing world.

Six years later, a panel of Nigerian medical experts concluded that Pfizer violated international law by testing an unapproved drug on children with brain infections at a field hospital, a lengthy government report given to The Post showed.

Authorities in Kano, the country's largest state, last year filed eight criminal charges related to the 1996 clinical trial, including counts of criminal conspiracy and voluntarily causing grievous harm. They also filed a civil lawsuit seeking more than $2 billion in damages and restitution from Pfizer.

By Derek Kravitz |  July 9, 2008; 2:15 PM ET
Previous: Dick Cheney's Continuing Environmental Influence | Next: Ethics Complaints Filed Over Obama Mortgage Rate

Comments

Please email us to report offensive comments.



Post a Comment

We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.

User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.




characters remaining

 
 

© 2010 The Washington Post Company